Clinton A.  Lewis, Jr. net worth and biography

Clinton Lewis, Jr. Biography and Net Worth

EVP of Zoetis
Prior to his current role, Mr. Lewis served in a series of senior executive roles at Zoetis, the global leader in the animal health industry including Executive Vice President and Group President responsible for international operations, commercial development, global genetics and aquaculture from 2018 to 2019, President of International Operations from 2015 to 2018 and as President of U.S. Operations from 2013 to 2015.  

Prior to the formation of Zoetis (IPO from Pfizer in 2013), Mr. Lewis served as President of U.S. Operations at Pfizer Animal Health, which he joined in 2007. Mr. Lewis first joined Pfizer in 1988 in the human health pharmaceutical segment and held positions of increasing responsibility in various commercial operations and general management roles. 

Mr. Lewis currently serves on the Board of Directors of International Paper (NYSE: IP) and also serves on the Board of United Veterinary Care. Mr. Lewis formerly served as Chairman of the Board for the Animal Health Institute (AHI), an industry trade association in the U.S., and served as Treasurer for International Federation for Animal Health (IFAH), an industry trade association in Europe. Mr. Lewis has also served on the Dean’s Advisory Board for both Cornell’s College of Veterinary Medicine and Western University’s College of Veterinary Medicine.  

How do I contact Clinton A. Lewis, Jr.?

The corporate mailing address for Mr. Lewis, Jr. and other Zoetis executives is 10 Sylvan Way, Parsippany NJ, 07054. Zoetis can also be reached via phone at (973) 822-7000 and via email at [email protected]. Learn More on Clinton A. Lewis, Jr.'s contact information.

Has Clinton A. Lewis, Jr. been buying or selling shares of Zoetis?

Clinton A. Lewis, Jr. has not been actively trading shares of Zoetis within the last three months. Learn More on Clinton A. Lewis, Jr.'s trading history.

Who are Zoetis' active insiders?

Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Gregory Norden (Director), Kristin Peck (CEO), Robert Polzer (EVP), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.

Are insiders buying or selling shares of Zoetis?

In the last twelve months, insiders at the sold shares 13 times. They sold a total of 49,823 shares worth more than $8,985,800.22. The most recent insider tranaction occured on March, 18th when EVP Roxanne Lagano sold 923 shares worth more than $159,983.59. Insiders at Zoetis own 0.2% of the company. Learn More about insider trades at Zoetis.

Information on this page was last updated on 3/18/2024.

Clinton A. Lewis, Jr. Insider Trading History at Zoetis

See Full Table

Clinton A. Lewis, Jr. Buying and Selling Activity at Zoetis

This chart shows Clinton A Jr. Lewis's buying and selling at Zoetis by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zoetis Company Overview

Zoetis logo
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
Read More

Today's Range

Now: $168.51
Low: $166.34
High: $168.51

50 Day Range

MA: $186.36
Low: $165.71
High: $199.94

2 Week Range

Now: $168.51
Low: $151.03
High: $201.92

Volume

2,857,739 shs

Average Volume

3,941,012 shs

Market Capitalization

$77.16 billion

P/E Ratio

33.24

Dividend Yield

1.04%

Beta

0.87